A study of Donor Ex-Vivo Lung Perfusion in United Kingdom lung transplantation (DEVELOP-UK)

ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)0 个研究点目标入组 408 人开始时间: 2012年2月6日最近更新: 2019年6月17日

适应症

试验速览

•1. Male or female patients
•2. Adult patients (aged over 18 years)
•3. Patients already on or added to the active waiting list for first lung transplant while the DEVELOP-UK study is in its recruitment phase
•4. Patients providing informed consent for participation in the DEVELOP-UK study at the time of study commencement or time of listing for transplant
•5. Patients reconfirming informed consent for the DEVELOP-UK study on the day of lung transplant
•Qualitative substudy:
•1. All patients who are eligible for the DEVELOP-UK trial
•2. Patients at Newcastle Hospitals NHS Foundation Trust and Royal Brompton and Harefield NHS Foundation Trust only
•3. All patients who consent to the DEVELOP-UK trial as a whole and the qualitative study specifically (regardless of whether they receive a transplant)
•4. Male & female participants
•5. Lower Age Limit 18 years

•1. Patients aged less than 18 years
•2. Patients listed for lung re-transplantation
•3. Patients listed for heart-lung transplantation
•4. Patients listed for live donor lobar transplant
•5. Patients not initially consented or signed EOI form for the DEVELOP-UK study prior to the day of lung transplant
•6. Patients not reconfirming consent for the DEVELOP-UK study on the day of lung transplant
•7. Patients in the ITU requiring invasive ventilation, ECMO or NovaLung support
•8. Patients enrolled in Trials within the preceding 12 months (please discuss with principal and chief investigators)
•Qualitative sub-study
•All patients who have not consented to the DEVELOP-UK trial from Manchester, Papworth and Birmingham sites.

发起方

ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)